(4S,4'S)-4,4'-Diisobutyl-1,1'-di-p-tolyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 250mg

(2E)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)acrylic acid, 1g

2-Amino-4-nitrobenzoic acid, 98.0%, 25g

N-[2-(4-Methylphenyl)-1-[(3-nitrophenyl)amino]-2-oxoethyl]-2-furancarboxamide, 25mg

1-(2,4-Dichlorobenzyl)-1H-indazole-3-carboxylic acid, 95.0%, 100mg

3-Methoxy-4-nitrobenzaldehyde, 95.0%, 10g

Plat ROTILABO® en acier inoxydable, 670 mm, 1 pièce

(2S,4R)-1-((S)-2-AMINO-3,3-DIMETHYLBUTANOYL)-4-HYDROXY-N-(4-(4-METHYLTHIAZOL-5-YL)BENZYL)PYRROLIDINE-2-CARBOXAMIDE, 95%, 100mg

3'-Bromo-[1,1'-biphenyl]-4-carboxylic acid, 97%, 1g

(Z)-Methyl docos-13-enoate, 90.0%, 1g

4-Amino-benzoic acid 2-methoxy-ethyl esteroxalic acid salt, 1g

2-(2,4-Dichlorobenzyl)-1H-benzo[d]imidazole, 95.0%, 25g

2,4-Dichlorophenylthioethanol, 98.0%, 5g